More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. Announces Robert “Bo” Brannin as Senior Director of Operations for Subsidiary Kannaway

Medical Marijuana, Inc. Announces Robert “Bo” Brannin as Senior Director of Operations for Subsidiary Kannaway

by adminAdrianRamirez | Oct 18, 2017 | Kannaway, Press Releases

SAN DIEGO, Oct.18, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary Kannaway®  LLC is welcoming Robert “Bo” Brannin as its new Senior...
Listen: Kannalife™ Sciences Spokesman Nick Lowery Joins Neuroscientist on The Cannabis Reporter to Discuss CBD Benefits for CTE

Listen: Kannalife™ Sciences Spokesman Nick Lowery Joins Neuroscientist on The Cannabis Reporter to Discuss CBD Benefits for CTE

by adminAdrianRamirez | Oct 15, 2017 | Kannalife Sciences, Media Coverage

Kannalife™ Sciences spokesman and former NFL player Nick Lowery recently joined The Cannabis Reporter to discuss the potential role cannabidiol (CBD) could play in the prevention and treatment of the debilitating degenerative brain disease, chronic traumatic...
Real Scientific Hemp Oil™ Featured in Interview with Hope4Harper Founder

Real Scientific Hemp Oil™ Featured in Interview with Hope4Harper Founder

by adminAdrianRamirez | Oct 14, 2017 | HempMeds, Media Coverage

Creator of Hope4Harper Penny Howard discusses role RSHO™ has played in her family’s day to day life. In a recent interview with the Carrollton Reader, Penny Howard reveals the story behind the organization’s annual Run4Hope, the purpose of Hope4Harper, and the...
AXIM BIOTECHNOLOGIES® HIGHLIGHTED IN LINKEDIN HEALTH ARTICLE AS A LEADER IN TACKLING CURRENT OPIOID CRISIS

AXIM BIOTECHNOLOGIES® HIGHLIGHTED IN LINKEDIN HEALTH ARTICLE AS A LEADER IN TACKLING CURRENT OPIOID CRISIS

by adminAdrianRamirez | Oct 14, 2017 | Media Coverage

A chewing gum developed by AXIM delivers CBD and other crucial cannabinoids A recent article published in LinkedIn’s Healthcare section on the current U.S. opioid addiction crisis focused on ways doctors themselves are trying to combat the growing epidemic. The...
Dr. Stuart Titus Discusses State of Medical Marijuana Industry with Larry Kudlow of The Financial Exchange

Dr. Stuart Titus Discusses State of Medical Marijuana Industry with Larry Kudlow of The Financial Exchange

by adminAdrianRamirez | Oct 13, 2017 | Media Coverage

Dr. Stuart Titus, President and CEO of Medical Marijuana, Inc., recently visited with Larry Kudlow on WRKO’s Financial Exchange program to discuss the current state of the medical marijuana industry. Dr. Titus joined Medical Marijuana, Inc. nearly ten years ago, first...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.